HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kappa-opiate-induced diuresis and changes in blood pressure: demonstration of receptor stereoselectivity using (+)- and (-)-tifluadom.

Abstract
(+)-Tifluadom injected i.p. produced a biphasic response of urine output: within the first hour of its administration the drug produced antidiuresis followed by a diuretic phase. In contrast, the (-) isomer produced a modest reduction in urine output as compared to the output of the saline-treated rats. In addition, (+)-tifluadom markedly reduced the output of urinary Na+ and K+. The effects of (+)-tifluadom were blocked by 7.5 mg/kg naloxone but not by 10 mg/kg of the benzodiazepine antagonist Ro 15-1788. Parallel experiments demonstrated that the i.v. administration of (+)-tifluadom to non-anesthetized rats caused a dose-related pressor response that lasted for at least 15 min. This effect of (+)-tifluadom was blocked and antagonized by naloxone. In contrast, (-)-tifluadom was either inactive on the cardiovascular system or produced short-lasting hypotension. In pentobarbital-anesthetized rats, 100 micrograms/kg (+)-tifluadom caused a precipitous hypotension that was reversed by naloxone but not by Ro 15-1788.
AuthorsH Ureta, L F López, A Pérez, J P Huidobro-Toro
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 135 Issue 3 Pg. 289-95 (Mar 31 1987) ISSN: 0014-2999 [Print] Netherlands
PMID3034631 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Electrolytes
  • Receptors, Opioid
  • Receptors, Opioid, kappa
  • Benzodiazepines
  • Naloxone
  • tifluadom
Topics
  • Anesthesia
  • Animals
  • Benzodiazepines (pharmacology)
  • Blood Pressure (drug effects)
  • Diuresis (drug effects)
  • Electrolytes (urine)
  • Female
  • Hemodynamics (drug effects)
  • Naloxone (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid (drug effects, metabolism)
  • Receptors, Opioid, kappa
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: